Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3692666015 | Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3692667012 | Antazoline sulfate 5 mg/mL and xylometazoline hydrochloride 500 microgram/mL eye drops | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
467924018 | Antazoline sulphate+xylometazoline hydrochloride 0.5/0.05% eye drops | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
467924018 | Antazoline sulphate+xylometazoline hydrochloride 0.5/0.05% eye drops | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
467925017 | Antazoline sulfate+xylometazoline hydrochloride 0.5/0.05% eye drops | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
467925017 | Antazoline sulfate+xylometazoline hydrochloride 0.5/0.05% eye drops | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
720719017 | Antazoline sulfate+xylometazoline hydrochloride 0.5/0.05% eye drops (substance) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1192135016 | Antazoline sulfate+xylometazoline hydrochloride 0.5/0.05% eye drops (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1192135016 | Antazoline sulfate+xylometazoline hydrochloride 0.5/0.05% eye drops (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3692665016 | Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3692666015 | Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3692667012 | Antazoline sulfate 5 mg/mL and xylometazoline hydrochloride 500 microgram/mL eye drops | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Is a | Product containing antazoline (medicinal product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Is a | Miscellaneous eye preparations | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Antazoline (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Is a | Antazoline sulfate+xylometazoline hydrochloride | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Antazoline sulfate (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Xylometazoline hydrochloride (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Bronchodilator | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Is a | Antazoline- and xylometazoline-containing product | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has manufactured dose form | Eye drops | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Is a | Product containing xylometazoline in ophthalmic dosage form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength denominator unit (attribute) | Milliliter (qualifier value) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength denominator unit (attribute) | Milliliter (qualifier value) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength numerator value | cinq | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has basis of strength substance (attribute) | Antazoline sulfate (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has precise active ingredient | Xylometazoline hydrochloride (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has precise active ingredient | Antazoline sulfate (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Has basis of strength substance (attribute) | Xylometazoline hydrochloride (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) | Is a | Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets